About Beijing Foyou Pharma Company

The company went public on June 30, 2022. The company is mainly engaged in R&D, production and sales of pharmaceutical preparations and medical devices. With the mission of “focusing on the pharmaceutical field and creating a healthy life together”, the company is committed to building a core competitive advantage integrating R&D, production and sales, continuously building large-scale product groups, forming a rich product line with combined advantages in “fields, varieties and technology”, and building an industrial value chain with a complete cycle from raw materials to pharmaceuticals. The company has been selected as a G20 enterprise in the Beijing Pharmaceutical Industry Leapfrog Development Project, ranked among the top 100 chemical drug research and development capabilities in China, and has been widely recognized within and outside the industry. The company is mainly engaged in R&D, production and sales of pharmaceutical preparations and medical devices, and its products have strong competitiveness and high market recognition. The company has a rich product range. Currently, pharmaceutical preparations mainly cover various product segments such as cardiovascular system, chronic nephropathy, dermatology, digestive system, diabetes, neuropsychiatry, gynecology, etc., with losartan potassium hydrochlorothiazide tablets, olmesartan tablets, telmisartan tablets, trimetazidine hydrochloride tablets, atorvastatin calcium tablets, compound α-ketoacid tablets, hasinide solution, pivermonium bromide tablets, caseru, reglinide tablets, glizil sustained-release tablets Many major products such as carbohydrate tablets, paroxetine hydrochloride tablets, venlafaxine hydrochloride sustained-release capsules, progesterone softgels, etc.; report During the period, the company's medical device business was mainly humidified oxygen absorption devices, and the main products included disposable oxygen suction tubes, etc. Company Honors: Beijing Biomedical Industry Leapfrogging Development Project (G20) - industry leading enterprise, high-tech enterprise.